This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Kyowa Kirin Co., Ltd.. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Hideo Ikota: Innovator in Anticancer Compounds
Introduction
Hideo Ikota is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer activity. His work is characterized by a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Hideo Ikota holds 2 patents related to his innovative work. His latest patents focus on a compound having anticancer activity, which includes a pharmaceutically acceptable salt. The compound is represented by a specific formula, where certain groups are selected from a defined set of formulas. This innovative approach aims to provide effective treatment options for cancer patients.
Career Highlights
Ikota's career is marked by his association with Kyowa Kirin Co., Ltd., a leading pharmaceutical company. His role at the company has allowed him to collaborate with other talented professionals in the field, contributing to groundbreaking research and development.
Collaborations
Throughout his career, Hideo Ikota has worked alongside notable colleagues such as Kenji Uchida and Ryohei Kawai. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their shared field of expertise.
Conclusion
Hideo Ikota's contributions to the development of anticancer compounds highlight his dedication to improving healthcare through innovation. His work continues to inspire future advancements in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile